News | February 12, 2008

ACC Accepts Presentation on HF Patient Management System

February 13, 2008 - Orqis Medical Corp’s MOMENTUM Trial Abstract was accepted for a late breaking clinical trial presentation at the upcoming American College of Cardiology (ACC) meeting, in which it will report on the hemodynamic and clinical effects of the percutaneous Cancion System in managing patients hospitalized with heart failure.

Barry Greenberg, M.D., director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and national principal investigator for the MOMENTUM Trial, will present, “Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results of the MOMENTUM Trial,” Tuesday, April 1, 2008, from 1:45 pm to 2:00 pm, at the McCormick Place convention center, North Hall B1, in Chicago, IL.

For more information: www.orqis.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Siemens, Sensis Vibe hemodynamic system, ACC 2016
Technology | Hemodynamic Monitoring Systems| April 01, 2016
Siemens will unveil a revamped version of its established Sensis hemodynamic system at the 65 th Annual Scientific...
Feature | Hemodynamic Monitoring Systems| January 12, 2016 | Dave Fornell
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, curren
Overlay Init